Specialties

Results from the VERTIS-CV trial suggest that ertugliflozin is not superior to placebo in reducing MACE but may reduce the rate of hospitalization for heart failure. 

Increased pericardial adipose tissue volume leads to coronary heart disease, coronary artery calcification, atrial fibrillation, and reduced left ventricular function. 

Getting an annual flu vaccine could help lower complications associated with diabetes.  

Beneficial cardiovascular results were consistent across subgroups regardless of diabetes status or medication combinations.

Guest Author: Dr. Cyaandi R. Dove, D.P.M
A recent trial showed a significant reduction in wound area by 73.1% with Single Use Negative Pressure Wound Therapy System (sNPWT). 

Numerous complications associated with diabetes, including the risk of death, begin at the pre-diabetic stage.

Findings from a recently published meta-analysis of patients with pre-diabetes, with and without ASCVD, suggest an increased risk for premature death and cardiovascular events.

The EarlyBird study investigated how to predict future pre-diabetes and type 2 diabetes in children. Years of research have shown us that there are many factors that predispose patients to type 2 diabetes. However, researchers at the University of Plymouth, in collaboration with Nestlé Institute of Health Sciences, monitored children …

The FDA has given a Fast Track Designation to accelerate study of Farxiga’s effect on reduction in mortality and heart failure after a heart attack.

Type 2 diabetes damages brain regions that govern memory, movement, and visual processing.